Literature DB >> 26794439

Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.

Mirjam Christ-Crain1, Wiebke Fenske2.   

Abstract

Copeptin and arginine vasopressin (AVP) are derived from a common precursor molecule and have equimolar secretion and response to osmotic, haemodynamic and stress-related stimuli. Plasma concentrations of copeptin and AVP in relation to serum osmolality are highly correlated. The physiological functions of AVP with respect to homeostasis of fluid balance, vascular tonus and regulation of the endocrine stress response are well known, but the exact function of copeptin is undetermined. Quantification of AVP can be difficult, but copeptin is stable in plasma and can be easily measured with a sandwich immunoassay. For this reason, copeptin has emerged as a promising marker for the diagnosis of AVP-dependent fluid disorders. Copeptin measurements can enable differentiation between various conditions within the polyuria-polydipsia syndrome. In the absence of prior fluid deprivation, baseline copeptin levels >20 pmol/l identify patients with nephrogenic diabetes insipidus. Conversely, copeptin levels measured upon osmotic stimulation differentiate primary polydipsia from partial central diabetes insipidus. In patients with hyponatraemia, low levels of copeptin together with low urine osmolality identify patients with primary polydipsia, and the ratio of copeptin to urinary sodium can distinguish the syndrome of inappropriate antidiuretic hormone secretion from other AVP-dependent forms of hyponatraemia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26794439     DOI: 10.1038/nrendo.2015.224

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  88 in total

1.  Differential diagnosis between diabetes insipidus and compulsive polydipsia.

Authors:  F DIES; S RANGEL; A RIVERA
Journal:  Ann Intern Med       Date:  1961-04       Impact factor: 25.391

2.  Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin.

Authors:  C Rivier; W Vale
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

Review 3.  Vasopressin function in the syndrome of inappropriate antidiuresis.

Authors:  R Zerbe; L Stropes; G Robertson
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

4.  Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy system of the rat.

Authors:  F Vandesande; K Dierickx
Journal:  Cell Tissue Res       Date:  1975-12-02       Impact factor: 5.249

Review 5.  Protein glucosylation and its role in protein folding.

Authors:  A J Parodi
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

6.  Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study.

Authors:  Katharina Timper; Wiebke Fenske; Felix Kühn; Nica Frech; Birsen Arici; Jonas Rutishauser; Peter Kopp; Bruno Allolio; Christoph Stettler; Beat Müller; Mira Katan; Mirjam Christ-Crain
Journal:  J Clin Endocrinol Metab       Date:  2015-03-13       Impact factor: 5.958

Review 7.  Lectin control of protein folding and sorting in the secretory pathway.

Authors:  Joseph D Schrag; Daniela O Procopio; Miroslaw Cygler; David Y Thomas; John J M Bergeron
Journal:  Trends Biochem Sci       Date:  2003-01       Impact factor: 13.807

8.  Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock.

Authors:  Nils G Morgenthaler; Beat Müller; Joachim Struck; Andreas Bergmann; Heinz Redl; Mirjam Christ-Crain
Journal:  Shock       Date:  2007-08       Impact factor: 3.454

9.  Gender and renal function influence plasma levels of copeptin in healthy individuals.

Authors:  Sanjay S Bhandari; Ian Loke; Joan E Davies; Ian B Squire; Joachim Struck; Leong L Ng
Journal:  Clin Sci (Lond)       Date:  2009-02       Impact factor: 6.124

10.  Structural organization of the rat gene for the arginine vasopressin-neurophysin precursor.

Authors:  H Schmale; S Heinsohn; D Richter
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  45 in total

Review 1.  Copeptin in the differential diagnosis of hypotonic polyuria.

Authors:  M Christ-Crain; W K Fenske
Journal:  J Endocrinol Invest       Date:  2019-07-31       Impact factor: 4.256

2.  Cross-Sectional Positive Association of Serum Lipids and Blood Pressure With Serum Sodium Within the Normal Reference Range of 135-145 mmol/L.

Authors:  Shouguo Gao; Xiangqin Cui; Xujing Wang; Maurice B Burg; Natalia I Dmitrieva
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-29       Impact factor: 8.311

3.  Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.

Authors:  Ron T Gansevoort; Maatje D A van Gastel; Arlene B Chapman; Jaime D Blais; Frank S Czerwiec; Eiji Higashihara; Jennifer Lee; John Ouyang; Ronald D Perrone; Katrin Stade; Vicente E Torres; Olivier Devuyst
Journal:  Kidney Int       Date:  2019-03-09       Impact factor: 10.612

4.  Changing the diagnostic approach to diabetes insipidus: role of copeptin.

Authors:  Anna Grandone; Pierluigi Marzuillo; Giuseppa Patti; Silverio Perrotta; Mohamad Maghnie
Journal:  Ann Transl Med       Date:  2019-12

5.  The Effects of Zinc Sulfate Supplementation on Serum Copeptin, C-Reactive Protein and Metabolic Markers in Zinc-Deficient Diabetic Patients on Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Razieh Hosseini; Farzaneh Montazerifar; Elham Shahraki; Mansour Karajibani; Ali Mohammad Mokhtari; Ali Reza Dashipour; Gordon A Ferns; Mohammad Jalali
Journal:  Biol Trace Elem Res       Date:  2021-03-03       Impact factor: 3.738

Review 6.  Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.

Authors:  Ewout J Hoorn; Robert Zietse
Journal:  J Am Soc Nephrol       Date:  2017-02-07       Impact factor: 10.121

Review 7.  Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?

Authors:  Peter Janssens; Caroline Weydert; Stephanie De Rechter; Karl Martin Wissing; Max Christoph Liebau; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2017-04-28       Impact factor: 3.714

8.  Adult neurogenesis of the median eminence contributes to structural reconstruction and recovery of body fluid metabolism in hypothalamic self-repair after pituitary stalk lesion.

Authors:  Yichao Ou; Mingfeng Zhou; Mengjie Che; Haodong Gong; Guangsen Wu; Junjie Peng; Kai Li; Runwei Yang; Xingqin Wang; Xian Zhang; Yawei Liu; Zhanpeng Feng; Songtao Qi
Journal:  Cell Mol Life Sci       Date:  2022-07-30       Impact factor: 9.207

9.  Synchronous pituitary and pineal gland lesions presenting with panhypopituitarism in a patient with widespread colorectal cancer: a case report.

Authors:  Tristan Struja; Joël Capraro
Journal:  Oxf Med Case Reports       Date:  2021-05-24

10.  Prognostic relevance of elevated plasma osmolality on admission in acute decompensated heart failure with preserved ejection fraction: insights from PURSUIT-HFpEF registry.

Authors:  Akito Nakagawa; Yoshio Yasumura; Chikako Yoshida; Takahiro Okumura; Jun Tateishi; Junichi Yoshida; Shunsuke Tamaki; Masamichi Yano; Takaharu Hayashi; Yusuke Nakagawa; Takahisa Yamada; Daisaku Nakatani; Shungo Hikoso; Yasushi Sakata
Journal:  BMC Cardiovasc Disord       Date:  2021-06-07       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.